Loading organizations...
LCY Group develops performance polymers, advanced materials, and specialty chemicals. It transforms traditional petrochemicals into low-carbon solutions for a circular economy, utilizing biomass, recycled materials, and fermentation technologies. The company also provides green electronic materials for semiconductor and interconnect applications, emphasizing sustainable processes in all offerings.
Founded in 1915 by the grandfather of current chairman Bowei Lee, LCY Group began as a lumber business. The founding insight involved adapting to evolving industrial demands, leading to a gradual transition into chemical manufacturing. This evolution enabled diversification into material science sectors, driven by a long-term vision for progress.
LCY Group's products serve global partners across manufacturing, electronics, and industries seeking sustainable material solutions. The company envisions a future powered by biological cycles and net-zero living, directing efforts towards pioneering green materials and specialty chemicals. Its mission is to create value through sustainable product development and advanced technological solutions.
LCY Group has 1 tracked investment across 1 company. The latest tracked deal is $30.0M Series B in Helium Health in June 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2023 | Helium Health | $30.0M Series B | — | Angel Labs, Asia Africa Investment & Consulting (aaic), AV8 Ventures, B Capital Group, Cantos Ventures, ALI Tamaseb, Global Ventures, Maven Ventures, Y Combinator, Anne Wojcicki, Tony XU, Angaza Capital, Jonathan Dean, Capria Ventures, Flat World Partners, Ohara Pharmaceutical, Reliance Health, Tencent Holdings, Western Technology Investment |